# Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

> **NCT05253937** · — · COMPLETED · sponsor: **Lithuanian University of Health Sciences** · enrollment: 160 (actual)

## Conditions studied

- Cardiopulmonary Arrest
- Epinephrine Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** Epinephrin

## Key facts

- **NCT ID:** NCT05253937
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2022-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05253937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05253937, "Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05253937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*